Loading clinical trials...
Loading clinical trials...
The Risks of Percutaneous Native Kidney Biopsy in Italy in the Third Millennium: a Prospective Cohort Study
The estimates risks and benefits of the percutaneous kidney biopsy have been reported mainly from retrospective studies. So far no prospective multicentre studies has been designed to identify rates of biopsy related complications. The aim of this prospective multicentre study was to evaluate safety and complication events related to biopsies on native kidney in Italy.
Kidney biopsies performed in 54 italian nephrology centres from 2012 to 2020 were included. Primary outcome of the study was any major complication, such as haemoglobin decrease more than 2 g/dL, macroematuria, gross ematoma, blood transfusion, artero-venous fistula, invasive intervention, pain, symptomatic hypotension, and/or rapid serum creatinine increase. Centre and individual patient risk predictors were analysed using multivariate logistic regression analysis.
Age
All ages
Sex
ALL
Healthy Volunteers
No
San Giovanni di Dio Hospital
Agrigento, Italy
Giovanni XXIII pediatric Hospital
Bari, Italy
Policlinico Hospital
Bari, Italy
S. Orsola Hospital
Bologna, Italy
Cannizzaro Hospital
Catania, Italy
S. Camillo Hospital
Chieti, Italy
Santa Croce Hospital
Cuneo, Italy
Maria SS. Addolorata Hospital
Eboli, Italy
University Hospital
Foggia, Italy
Policlinico Hospital
Messina, Italy
Start Date
January 3, 2012
Primary Completion Date
August 4, 2020
Completion Date
May 31, 2021
Last Updated
July 2, 2021
5,304
ACTUAL participants
Native kidney biopsy
PROCEDURE
Lead Sponsor
Simeone Andrulli, MD
NCT06656988
NCT04592640
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions